Evommune
EVMN· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Luis Peña is the CEO of Evommune and was paid $11.0M in FY2025 (Dec), up 48%.
PayNo stock prices for these years
Executives3
See all- 1Luis PeñaChief Executive OfficerFY2025
- 2Gregory S. MossChief Business & Legal OfficerFY2025
- 3Kyle CarverChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allEvommune paid its 3 named executives $20.0M in total in FY2025 (Dec). CEO Luis Peña was paid $11.0M of that.
| Name | ||
|---|---|---|
| Luis PeñaChief Executive Officer | ||
| Gregory S. MossChief Business & Legal Officer | ||
| Kyle CarverChief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Evommune. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board3
See all- Rob Hopfner, R.Ph.Director · 5 yr on the boardIndependentAudit, Science and Technology—Paid as an executive
- Felice Verduyn-van WeegenDirector · 4 yr on the boardIndependentNominating and Corporate Governance, Science and Technology—Paid as an executive
- Derek DiRoccoDirector · 1 yr on the boardIndependentScience and Technology—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings2
See all| Proxy statement | DEF 14A | Apr 21, 2026 | FY2025 |
| Annual report | 10-K | Mar 5, 2026 | FY2025 |
